Vivos Inc (RDGL): Agree! I still think IDE will be submit...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: wrinklesobw post# 148023

Tuesday, 06/28/2022 8:15:06 PM

Tuesday, June 28, 2022 8:15:06 PM

Agree! I still think IDE will be submitted late Q3 and approved early Q4. Human trials start Q1 2023.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 07/15/2024 10:02:55 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM

InvestorsHub NewsWire

Only $200 per official company press release!